Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Gutierrez

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Comparative Effectiveness Research|January 23, 2020
Strengthening pharma's contract with society: the value of trusted partnerships between pharma and healthcare facilitated by real-world dataMichael J Seewald, Jonathan M Plumb, Ben Gutierrez, et al.
Expert Review of Hematology|September 1, 2021
Belantamab mafodotin for the treatment of relapsed/refractory multiple myeloma in heavily pretreated patients: a US cost-effectiveness analysisAndreas Nikolaou, Apoorva Ambavane, Anshul Shah, et al.
Therapeutic Innovation & Regulatory Science|July 8, 2020
Bridging the Gap Between RCTs and RWE Through Endpoint SelectionRobert J LoCasale, Chris L Pashos, Ben Gutierrez, et al.
Annals of Botany|June 14, 2022
Tannin phenotyping of the Vitaceae reveals a phylogenetic linkage of epigallocatechin in berries and leavesJean-Marc Brillouet, Charles Romieu, Roberto Bacilieri, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Comparative Effectiveness Research|January 23, 2020
Strengthening pharma's contract with society: the value of trusted partnerships between pharma and healthcare facilitated by real-world dataMichael J Seewald, Jonathan M Plumb, Ben Gutierrez, et al.
Expert Review of Hematology|September 1, 2021
Belantamab mafodotin for the treatment of relapsed/refractory multiple myeloma in heavily pretreated patients: a US cost-effectiveness analysisAndreas Nikolaou, Apoorva Ambavane, Anshul Shah, et al.
Therapeutic Innovation & Regulatory Science|July 8, 2020
Bridging the Gap Between RCTs and RWE Through Endpoint SelectionRobert J LoCasale, Chris L Pashos, Ben Gutierrez, et al.
Annals of Botany|June 14, 2022
Tannin phenotyping of the Vitaceae reveals a phylogenetic linkage of epigallocatechin in berries and leavesJean-Marc Brillouet, Charles Romieu, Roberto Bacilieri, et al.
Pageof 1